Answer
Yes, Symtuza is contraindicated in people with severe hepatic impairment classified as Child-Pugh Class C.
Sources for this answer
- Symtuza 800 mg/150 mg/200 mg/10 mg film coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 17Document updated
Sources checked